Limb salvage · 52 people with TASC‐II D superficial femoral artery chronic total occlusions
1 finding from 1 review
Complications · 52 people with TASC‐II D superficial femoral artery chronic total occlusions
1 finding from 1 review
Clinical improvement · 52 people with TASC‐II D superficial femoral artery chronic total occlusions
1 finding from 1 review
Duration of crying (seconds) · Infants 1 to 12 months during vaccination
1 finding from 1 review
All pain scores during injection Due to range of pain scores used, data analysed using SMDs. Pain scores were measured during and up to 3 minutes following completion of vaccination. · Infants 1 to 12 months during vaccination
2 findings from 1 review
Heart rate · Infants 1 to 12 months during vaccination
1 finding from 1 review
Adverse events · Infants 1 to 12 months during vaccination
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Resolution of ear discharge at short‐term
Antibiotic eardrops (with or without a corticosteroid) probably leads to higher resolution of ear discharge at short‐term compared with oral antibiotics (moderate certainty).
1 finding from 1 review
Adverse events
Antibiotic eardrops (with or without a corticosteroid) showed no clear difference in adverse events compared with oral antibiotics (low certainty).
1 finding from 1 review
Serious complications
1 finding from 1 review
Resolution of ear discharge at intermediate‐term
Antibiotic eardrops (with or without a corticosteroid) probably leads to higher resolution of ear discharge at intermediate‐term compared with oral antibiotics (moderate certainty).
1 finding from 1 review
Duration of ear discharge
1 finding from 1 review
Tube blockage
Antibiotic eardrops (with or without a corticosteroid) showed no clear difference in tube blockage compared with oral antibiotics (low certainty).
1 finding from 1 review
Health‐related quality of life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Generic ‐ CHQ
1 finding from 1 review
Disease‐specific quality of life
1 finding from 1 review
Adverse effects: urinary incontinence · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether antidepressants (trazodone 200 mg/day) changes adverse effects: urinary incontinence compared with placebo (very low certainty).
1 finding from 1 review
Gastrointestinal adverse events · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether dietary supplements (alpha lipoic acid +/- adjunctive ingredients) changes adverse effects: gastrointestinal complaints compared with placebo (very low certainty).
1 finding from 1 review
Change in taste · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects: mild headache · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether anticonvulsants (gabapentin + alpha lipoic acid) changes adverse effects: mild headache compared with placebo (very low certainty).
1 finding from 1 review